盐酸二甲双胍及其制剂的研究进展
田长青,赵刚,李静,苏庆
摘要(Abstract)：
<正>盐酸二甲双胍是治疗糖尿病的双胍类降糖药,目前,二甲双胍已被认为是胰岛素增敏剂之一,可有效降低血糖,改善胰岛素抵抗。与胰岛素和磺脲类降糖药相比,它对超重糖尿病患者可强化血糖控制,且不增加低血糖的发生,也不增加体重,还可降低大小血管并发症的发生率。英国前瞻性糖尿病研究表明,盐酸二甲双胍可作为治疗2型糖尿病的一线用药。我们就近年来对盐酸二甲双胍药理作用及其制
关键词(KeyWords)：
基金项目(Foundation):
作者(Author): 田长青,赵刚,李静,苏庆
DOI: 10.19577/j.cnki.issn10074406.2007.03.023
参考文献(References)：
- [1]Stolar MW.Insulin resistance,diabetes,and the adipocyte[J].Am J Health Syst Pharm ,2002,59(Suppl 9):S3.
- [2]Otto M,Bremholt J,Westergaard N.Metformin inhibits glycogen syn- thesis and glyconecgensis in cultured rat hepatocytes[J].Diabetes Obes Metab,2003,5(3):189.
- [3]Owen MR,Doran E,Halestrap AP.Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain[J].Biochem,2000,15:348.
- [4]Ysuda N,Inoue T,Nagakura T,et al.Enhanced secretion of glucagons like peptideⅠby biguanide compounds[J].Biochem Biophys Res Com- mun,2002,298(5):779.
- [5]Valensi P,Behar A,Cohen Boulakiu F.In vivo kinetics of 123 iodine- labelled insulin in skeletal muscle of patients with type 2 diabetes.Effect of metformin[J].Diabetes Metab,2002,28:95.
- [6]Gunton JE,Delhanty PJ,Takahazh S,et at.Metformin rapidly increases insulin receptor activation in human liver and signals preferentially through insulin-receptor substrate-2[J].J Clin Endocrinol Metab,2003, 88(3):133.
- [7]Luna V,Cazowban L,Sajan MP,et al.Metformin improves a typical protein kinase C activation by insulin and phosphatidylinosite-3,4,5- (PO4)3 in musce of liabetic subjects[J].Diabetologia,2006,49(2): 375.
- [8]Ascic-Buturovic B.The effect of combined insulin and metformin therapy in obese patients with diabetes mellitus type 2 in the early stage of the disease[J].Bosh J Basi Med Sci,2006,6(2):54.
- [9]Mogul HR,Peterson SJ,Weinstein BJ.Metformin and carbohydrate modi- fied diet,a novel obesity protocol:preliminary findings from a case series of nondiabetic women with midlife weight gain and hyperinsulinemia[J]. Heart Dis,2001,3(5):285.
- [10]Lupi R,Del Guerna S,Fiernbracci V.Lipotoxicity in human pancreat- ic islets and the protective effect of metformin[J].Diabetes,2002,51 (1):134.
- [11]Legtenberg RJ,Houston RJ,Qeseburg B,et al.Metformin improves cardiac functional recovery after ischemia in rats[J].Horm Metab Res, 2002,34:183.
- [12]Stepensky D,Firedman M,Tay I,et a,.Pharmacokinetic-pharmacody- namic analysis of the glucose lowering effect of metformin in diabetic rats reveals first-pass pharmacodynamic effect[J].Drug Metabolism and Disposition,2002,30(8):861.
- [13]Setter SM,Iltz JL,Thams J,et al.Metformin hydrochloride in the treat- ment of type 2 diabetes mellitus:a clinical review with a focus on dual therapy[J].Clin Ther,2003,25(12):2991.
- [14]Marathe PH,Wen Y,Norton J,et al.Effect of altered gastric empty- ing and gastrointestinal motility on metformin absorption[J].Br J Clin Pharmacol,2000,50(4):325.
- [15]Cheng CL,Yu LX,Lea HL,et al.Biowaiver extension potential to BCS ClassⅢhigh solubility-low permeability drug:bridging evidence for metformin immediate-release tablet[J].Eur J Pharm.Sci,2004,22 (4):297.
- [16]Wong PSL,Yan D,Guitlard GV.Compositions and dosage forms for en- hanced absorption of iron[P].US:WO 2005/041928 A1,2005-05-12.
- [17]Hu LD,Liu Y,Tang X,et al.Preparation and in vitro/in vivo evalua- tion of sustained-release metformin hydrochloride pellets [J].Eur J Phann Biopharm,2006,64(2):185.
- [18]Fujuoka K,Pans M,Joyal S.Glycemic control in patients with type 2 diabetes mellitus switched from twice-daily immediate-release metformin to a once daily extended-release formulation[J].Clin Ther,2003,25 (2):515.